New target for CAR T cell leukemia therapy “gives hope” to researchers at Stanford, NCI – Scope (blog)
Scope (blog) |
New target for CAR T cell leukemia therapy “gives hope” to researchers at Stanford, NCI
Scope (blog) Last August, a new leukemia therapy called CAR T-cells burst onto the national stage when it was approved by the Food and Drug Administration to treat children and young adults with acute lymphoblastic leukemia for whom all other treatments had failed. Clinical trial suggests new cell therapy for relapsed leukemia patients |
